Patient-derived cell models could prove to be a useful tool to investigate ALS disease mechanisms given the ability to capture similar ALS-like cell death pathways and TDP-43 mislocalisation as a hallmark of disease progression [237,238]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.